F-18-Labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging

Debus, Fabian; Herth, Matthias M.; Piel, Markus; Buchholz, Hans-Georg; Bausbacher, Nicole; Kramer, Vasko; Lueddens, Hartmut; Roesch, Frank

Abstract

Introduction: The serotonergic system, especially the 5-HT2A receptor, is involved in various diseases and conditions. It is a very interesting target for medicinal applications. Methods: Two novel 5-HT2A tracers, namely, [F-18]DD-1 and the enantiomeric pure (R)-[F-18]MH.MZ, were radiolabeled by F-18-fluoroalkylation of the corresponding desmethyl analogue. In vitro binding autoradiography on rat brain slices was performed to test the affinity and selectivity of these tracers. Moreover, first mu PET experiments of (R)-[F-18]MH.MZ were carried out in Sprague-Dawley rats. Results: [F-18]DD-1 (K-i=3.23 nM) and (R)-[F-18]MH.MZ (K-i=0.72 nM) were F-18-fluoroalkylated by the secondary synthon [F-18]FETos in a radiochemical yield (RCY) of >70%. The final formulation for both tracers took no longer than 100 min with an overall RCY of similar to 40%. It provided [F-18]tracers with a purity >96% and a typical specific activity of 25-35 GBq/mu mol. Autoradiographic images of (R)-[F-18]MH.MZ (5) and [F-18]DD-1 (4) showed excellent visualization and selectivity of the 5-HT2A receptor for (R)-[F-18]MH.MZ and less specific binding for [F-18]DD-1. The binding potential (BP) of (R)-[F-18]MH.MZ was determined to be 2.6 in the frontal cortex and 2.2 in the cortex (n=4), whereas the cortex-to-cerebellum ratio was determined to be 3.2 at steady state (n=4). Cortex-to-cerebellum ratios of (R)-[F-18]MH.MZ were almost twice as much as compared with the racemic [F-18]MH.MZ. Thereby, equal levels of specific activities were used. High uptake could be demonstrated in cortex regions. Conclusion: Labeling of both novel tracers was carried out in high RCY. Autoradiography revealed (R)-[F-18]MH.MZ as a very selective and affine 5-HT2A tracer (K-i=0.72 nM), whereas [F-18]DD-1 showed no reasonable distribution pattern on autoradiographic sections. Moreover, results from mu PET scans of (R)-[F-18]MH.MZ hint on improved molecular imaging characteristics compared with those of [F-18]MH.MZ. Therefore, (R)-[F-18]MH.MZ appears to be a highly potent and selective serotonergic PET ligand in small animals. (C) 2010 Elsevier Inc. All rights reserved.

Más información

Título según WOS: ID WOS:000277701900013 Not found in local WOS DB
Título de la Revista: NUCLEAR MEDICINE AND BIOLOGY
Volumen: 37
Número: 4
Editorial: Elsevier Science Inc.
Fecha de publicación: 2010
Página de inicio: 487
Página final: 495
DOI:

10.1016/j.nucmedbio.2010.02.002

Notas: ISI